Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers

The influenza A/Ann Arbor/6/60 (H2N2) cold-adapted (ca) virus was evaluated as a donor of attenuating genes to new variants of influenza A virus. This ca donor virus was mated with the A/Alaska/6/77 (H3N2) wild-type virus, and three A/Alaska/6/77 (H3N2) ca recombinant viruses were produced. The parental origin of the genes in the three ca recombinants had been determined previously (2), and their virulence for adult seronegative volunteers was assessed in the present study to identify the genes present in the ca donor virus that confer attenuation. Each of the recombinants received the hemagglutinin and neuraminidase genes from the A/Alaska/6/77 (H3N2) wild-type parent. One ca recombinant (CR-29) received all six transferable genes from the ca parent and was found to be satisfactorily attenuated in the volunteers. The two other ca recombinants received five of the six transferable genes with a wild-type gene at the M or NS locus. The pattern of infection in humans with these latter two ca recombinants was similar to the CR-29 ca recombinant. These findings demonstrate that inheritance of a gene in ca recombinants at the M or NS locus segregates independently of attenuation and suggest that the M and NS genes present in the ca donor virus are not the major determinants of attenuation conferred by this virus.

[1]  H. Maassab,et al.  Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. , 1977, The Journal of infectious diseases.

[2]  C. Scholtissek,et al.  Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains. , 1979, Virology.

[3]  H. Maassab,et al.  Laboratory and clinical characteristics of attenuated strains of influenza virus. , 1969, Bulletin of the World Health Organization.

[4]  R. Chanock,et al.  Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease. , 1980, Reviews of infectious diseases.

[5]  H. Maassab,et al.  Biologic and immunologic characteristics of cold-adapted influenza virus. , 1969, Journal of immunology.

[6]  R. Chanock,et al.  Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. , 1980, Infection and immunity.

[7]  H. Maassab,et al.  Adaptation and Growth Characteristics of Influenza Virus at 25° C , 1967, Nature.

[8]  R. Chanock,et al.  Genetic approaches to attenuation of influenza A viruses for man. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[9]  C. Scholtissek,et al.  Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains. , 1979, The Journal of general virology.

[10]  N. Cox,et al.  Comparative studies of wild-type and 'cold-mutant' (temperature sensitive) influenza viruses: geneology of the matrix (M) and non-structural (NS) proteins in recombinant cold-adapted H3N2 viruses. , 1977, The Journal of general virology.

[11]  V. Knight.  THE USE OF VOLUNTEERS IN MEDICAL VIROLOGY. , 1964, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[12]  R. Chanock,et al.  Cold-Adapted Variants of Influenza A Virus: Evaluation in Adult Seronegative Volunteers of A/Scotland/840/74 and A/Victoria/3/75 Cold-Adapted Recombinants Derived from the Cold-Adapted A/Ann Arbor/6/60 Strain , 1979, Infection and immunity.

[13]  R. Chanock,et al.  Cold-adapted variants of influenza virus A. I. Comparison of the genetic properties of ts mutants and five cold-adapted variants of influenza virus A. , 1977, Virology.

[14]  N. Cox,et al.  Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. , 1979, Virology.

[15]  R. Yolken,et al.  Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines , 1980, Infection and immunity.

[16]  R. Chanock,et al.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man. , 1972, The Journal of infectious diseases.

[17]  H. Maassab,et al.  A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers. , 1977, Developments in biological standardization.